Agitation and Depression in Frail Nursing Home Elderly Patients with Dementia: Treatment Characteristics and Service Use
Agitation and depression are the two most common behavioral complications of dementia. Although the behavioral symptoms have received less attention than the cognitive symptoms of dementia, they have serious consequences, including caregiver stress, premature institutionalization, and compromised quality of life for patients and their families.
This study suggests that dementia complicated by mixed agitation and depression is among the most clinically challenging problems in long-term care, and that effective interventions and services are needed to address the complex treatment needs of this high-risk group.
Due to copyright issues, this article is only available through the American Journal of Geriatric Psychiatry website.
Test Blog Post
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce luctus arcu sed erat malesuada tincidunt. Ut commodo ante et tortor egestas nec...
Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Patients, Research and Access to Health Care
Myrl Weinberg, FASAE, CAE, president of the National Health Council, says that it's important to for individuals, especially those with chronic...Chronic Health Conditions & Individual Treatment Effects
Dr. Ken Thorpe, chairman of the Partnership to Fight Chronic Disease, explains that one of the biggest health care challenges is managing patients...
Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council’s Chairman of the Board
WASHINGTON, DC (November 2, 2012)–The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo,...Study Quantifies Impact of Pharmaceuticals on Enhanced Productivity
(WASHINGTON, DC, August 1, 2012)–The costs to employers of chronic health conditions on employee productivity are well documented, but few studies...Pharmaceuticals Play Key Role in Achieving ACO Quality, Cost Goals
WASHINGTON, DC, July 18, 2012–As health care providers set up accountable care organizations (ACOs) and other value-based care programs,...New Survey Shows Employers Eyeing CER, PCORI for Health Information
Washington, DC, June 22, 2011--Employers are aware of comparative effectiveness research (CER) and its potential to answer critical questions about...Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...The Risks of Standardized Health Care
Think about the last time you visited a medical office. Even at a specialist’s office, chances are that each person waiting for his or her name to be...Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals
Medications are more than an item on the balance sheet for health care providers. Pharmaceuticals offer a route to manage costs while achieving...AMCP Call for Comment on Addenda/Appendices to AMCP’s Format for Formulary Submissions Version 3.0
The National Pharmaceutical Council (NPC) welcomes the opportunity to comment on the Format addendum on Comparative Effectiveness Research (CER). As...Patients, Research and Access to Health Care
Myrl Weinberg, FASAE, CAE, president of the National Health Council, says that it's important to for individuals, especially those with chronic...Chronic Health Conditions & Individual Treatment Effects
Dr. Ken Thorpe, chairman of the Partnership to Fight Chronic Disease, explains that one of the biggest health care challenges is managing patients...Challenges for Patients Seeking Health Information
Dr. Stephen Hume, Alzheimer's patient representative, and his care partner, Candace Darcy, discuss the need for patients to have as much information...Comparative Effectiveness Research in Medicare Decision-Making
At the June 2011 Drug Information Association Annual Meeting, NPC asked Dr. Marcel Salive for his thoughts on how comparative effectiveness research...Test Blog Post
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce luctus arcu sed erat malesuada tincidunt. Ut commodo ante et tortor egestas nec...Research
Component Management Fails to Save Health Care System Costs: The Case of Restrictive Formularies
The general failure of formularies and other limitat
Pain: Current Understanding of Assessment, Management, and Treatments
Pain is the most common reason individuals seek heal
Pharmaceuticals for Elders: Why Innovation Matters
The current policy debate over drug-benefit reform a
- 1 of 23
- >
Commentary & Testimony
Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
The Risks of Standardized Health Care
Framework Helps ACOs Leverage Pharmaceuticals to Realize Quality, Cost Goals
AMCP Call for Comment on Addenda/Appendices to AMCP’s Format for Formulary Submissions Version 3.0
Comparative Effectiveness Research and the Changing Health Care Landscape